Navigation Links
Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences
Date:5/12/2008

SAN DIEGO, May 12 /PRNewswire-FirstCall/ -- Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) announced today that it will present at the Rodman & Renshaw 5th Annual Global Healthcare Conference on Monday, May 19, 2008 at 10:00 a.m. CEST (4:00 a.m. EDT/1:00 a.m. PDT) at Le Meridien Beach Plaza Hotel in Monte Carlo, Monaco. Steve Worland, Ph.D., President and Chief Executive Officer of Anadys, will present an overview of Anadys and an update on its two development-stage product candidates, ANA598 and ANA773.

Anadys will also present at the JMP Securities Research Conference on Monday, May 19, 2008 at 3:30 p.m. PDT (6:30 p.m. EDT) at the Ritz-Carlton Hotel in San Francisco. James L. Freddo, M.D., Chief Medical Officer of Anadys, will present an overview of Anadys and an update on its two development-stage product candidates, ANA598 and ANA773.

Each presentation will be webcast at the time of presentation and can be accessed on the Investor Relations page of the Company's website at http://www.anadyspharma.com. Listeners are encouraged to visit the website approximately five minutes prior to each presentation to download or install any necessary software. A replay of the presentations will be available approximately one hour after the live webcasts conclude and will be available through June 2, 2008.

About Anadys

Anadys Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to improving patient care by developing novel medicines in the areas of hepatitis C and oncology. The Company is developing ANA598, a non-nucleoside polymerase inhibitor for the treatment of chronic hepatitis C and ANA773, an oral TLR7 agonist prodrug for cancer.

Sa
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Anadys Pharmaceuticals Reports First Quarter 2008 Financial Results and Highlights
2. Anadys Pharmaceuticals to Report First Quarter 2008 Financial Results
3. Anadys Pharmaceuticals to Present at the CanAccord Adams Hepatitis C Conference
4. Anadys Pharmaceuticals to Present at the Cowen and Company Healthcare Conference
5. Anadys Pharmaceuticals Commences Phase I Clinical Trial of ANA773 in Cancer Patients
6. Anadys Pharmaceuticals to Present at the Susquehanna SIGnificant Options in Healthcare Conference
7. Anadys Pharmaceuticals to Report Fourth Quarter and Year-End 2007 Financial Results
8. Anadys Pharmaceuticals to Present at the BIO CEO & Investor Conference
9. Anadys Pharmaceuticals to Present at the JPMorgan Healthcare Conference
10. Anadys Pharmaceuticals to Present at the Piper Jaffray Health Care Conference
11. Anadys Pharmaceuticals Reports Third Quarter 2007 Financial Results and Operational Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/16/2010)... Stock Exchange Symbol: MS , ... , , ... ... EDMONTON , March 16 ... ...
(Date:3/16/2010)... PharmAthene, Inc. (Amex: PIP ) a biodefense company developing medical countermeasures against biological and chemical threats, announced today that its financial results ... ... , ... ... ...
(Date:3/16/2010)... March 16 The Gynecologic Cancer Foundation (GCF) and the Claudia ... as the first recipient of the $50,000 GCF/Claudia Cohen Prize for Outstanding ... (SGO) 41st Annual Meeting on Women,s Cancer, meeting in San Francisco ... ... ...
(Date:3/16/2010)... (LSE: SHP,NASDAQ; SHPGY), announces that it has received a Paragraph IV Notice ... New Drug Application ("ANDA") for a generic version of Shire,s 1,mg, 2mg, ... ... ... , ...
Breaking Biology Technology:BioMS Medical Announces 2009 Year End Results 2BioMS Medical Announces 2009 Year End Results 3BioMS Medical Announces 2009 Year End Results 4BioMS Medical Announces 2009 Year End Results 5BioMS Medical Announces 2009 Year End Results 6BioMS Medical Announces 2009 Year End Results 7BioMS Medical Announces 2009 Year End Results 8BioMS Medical Announces 2009 Year End Results 9BioMS Medical Announces 2009 Year End Results 10PharmAthene to Host Year-End 2009 Earnings Conference Call and Webcast on Tuesday, March 23, 2010 2PharmAthene to Host Year-End 2009 Earnings Conference Call and Webcast on Tuesday, March 23, 2010 3Paul Goodfellow, PhD, Awarded First GCF/Claudia Cohen Prize for Outstanding Gynecologic Cancer Researcher 2Paul Goodfellow, PhD, Awarded First GCF/Claudia Cohen Prize for Outstanding Gynecologic Cancer Researcher 3Paul Goodfellow, PhD, Awarded First GCF/Claudia Cohen Prize for Outstanding Gynecologic Cancer Researcher 4Paul Goodfellow, PhD, Awarded First GCF/Claudia Cohen Prize for Outstanding Gynecologic Cancer Researcher 5Shire Receives INTUNIV (TM) Paragraph IV Notice Letter From Teva Pharmaceuticals 2Shire Receives INTUNIV (TM) Paragraph IV Notice Letter From Teva Pharmaceuticals 3Shire Receives INTUNIV (TM) Paragraph IV Notice Letter From Teva Pharmaceuticals 4
... ETEX Corporation, an advanced,biomaterials company, announced today ... EquivaBone(TM) is a bone graft substitute,that remodels ... the healing process., (Logo: http://www.newscom.com/cgi-bin/prnh/20080424/NETH117LOGO ... CEO of ETEX Corporation, states, "ETEX is,excited ...
... HILL, N.C., Aug. 15 The U.S. ... into multiple market,segments. In this challenging marketplace, ... complex organizational and,decision-making structures to effectively represent ... being influenced by medical professionals,focused on efficacy ...
... Biotechnology and Green Chemistry Events Added, PRINCETON, ... for InformexUSA 2009 is now open and may ... sellers of higher value chemicals,specialty materials, biotechnology and ... to receive a discount on registration,fees. The upcoming ...
Other Biology Technology:ETEX Launches Innovative Osteoinductive Orthobiologic, EquivaBone(TM) 2U.S. Hospital Sales Opportunities Maximized Through Functional Optimization 2Informex Opens Registration to InformexUSA 2009 2Informex Opens Registration to InformexUSA 2009 3
(Date:3/18/2010)... can live for twenty years, fertilizing millions of eggs ... activity. , Danish researchers who have studied ants ... 1992 discovered that in both ant and bee species ... fluid favors the survival of its own sperm over ... stored, leafcutter ant queens neutralize male-male sperm competition with ...
(Date:3/18/2010)... available in Spanish . , Feeding ... as part of their regular diet makes them ... a study by Agricultural Research Service (ARS) scientists ... and overall behavioral activity among young female pigs ... acquired through diet, is the precursor for the ...
(Date:3/18/2010)... Biotech, Inc., ( www.genwaybio.com ) the US-based diagnostic company ... is expanding this cancer testing program internationally. An ... YouTM Cancer Assessment in Greece starting in April. ... as well. GenWay currently offers this test in ... Sergey Sikora, Vice President of Business Development, said, "The ...
Breaking Biology News(10 mins):Females shut down male-male sperm competition in leafcutter ants 2Tryptophan-enriched diet reduces pig aggression 2Moravia Worldwide Names George Krawczyk as Sales Director for Ireland and UK 61905 1Moravia Worldwide Names George Krawczyk as Sales Director for Ireland and UK 61905 2Barbara Fentress Designer of the Denver International Airport and Convention Center Offers Her Private Mansion at Absolute Auction 61902 1Barbara Fentress Designer of the Denver International Airport and Convention Center Offers Her Private Mansion at Absolute Auction 61902 2Ophthalmic Equipment Distributor Latham 26amp 3B Phillips SE Division Unveils Website 61899 1Ophthalmic Equipment Distributor Latham 26amp 3B Phillips SE Division Unveils Website 61899 2Ophthalmic Equipment Distributor Latham 26amp 3B Phillips SE Division Unveils Website 61899 3
... ancestral line of parasitic bacteria, scientists can glean a lot ... lived or who you spent time with. It turns out ... , Stanford researchers with collaborators at Tel-Aviv University have now ... past using a technique called "reverse ecology." The technique uses ...
... statistical model could be used to predict an individual,s ... Children,s Hospital Informatics Program (CHIP). Using genetic information from ... model could estimate an individual,s overall risk of cardioembolic ... with 86 percent accuracy. The findings are reported in ...
... scientists who found warning signs of climate change in ... will share the 2009 Tyler Prize for Environmental Achievement. ... prize and gold medals, will go to Richard Alley, ... (Ram) Ramanathan, professor of atmospheric and climate sciences in ...
Other Biology News:Reversing ecology reveals ancient environments 2Predicting risk of stroke from one's genetic blueprint 2Winners of Tyler environmental prize announced 2
...
... ISOQUANT(R) Isoaspartate Detection Kit is intended for ... proteins and peptides, which can result from ... rearrangement of aspartic acid residues during storage ... depend on the monitoring of charge differences ...
...
...
Biology Products: